Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Verhoeyen

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Molecular Therapy. Nucleic Acids|December 16, 2024
Engineered packaging cell line for the enhanced production of baboon-enveloped retroviral vectorsDenise Klatt, Lucia Sereni, Boya Liu, et al.
Gene Therapy|January 19, 2026
Baboon endogenous retrovirus (ERV) envelope pseudotyped lentiviral vectors outperform human ERV lentivectors for transduction of T, B, NK and HSPCsSéverine Périan, Eva Castellano, Caroline Costa, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2024
In vivo CAR T cell therapy against angioimmunoblastic T cell lymphomaAdrien Krug, Aymen Saidane, Chiara Martinello, et al.
Blood|November 26, 2011
A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized miceCecilia Frecha, Caroline Costa, Didier Nègre, et al.
Cells|February 26, 2026
Engineering Bi-Specific CAR-NK Cells to Restore Antibody-Dependent Cellular Cytotoxicity in Solid TumorsJee Young Chung, Jung Eun Kim, Daseuri Cha, et al.
Molecular Therapy. Methods & Clinical Development|January 4, 2019
CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor CellsStosh Ozog, Craig X Chen, Elizabeth Simpson, et al.
Molecular Therapy. Oncology|May 22, 2026
Engineering precision oncology: Targeting tumors and immune cells with lentiviral vectorsJulia Rossi, Chiara Martinello, Riccardo Sorrentino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 24, 2012
Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cellsCamille Lévy, Fouzia Amirache, Caroline Costa, et al.
Journal of Virology|April 1, 2011
Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptorsCecilia Frecha, Camille Lévy, Caroline Costa, et al.
Advances in Virology|March 21, 2014
Mutations in the H, F, or M Proteins Can Facilitate Resistance of Measles Virus to Neutralizing Human Anti-MV SeraHasan Kweder, Michelle Ainouze, Sara Louise Cosby, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Molecular Therapy. Nucleic Acids|December 16, 2024
Engineered packaging cell line for the enhanced production of baboon-enveloped retroviral vectorsDenise Klatt, Lucia Sereni, Boya Liu, et al.
Gene Therapy|January 19, 2026
Baboon endogenous retrovirus (ERV) envelope pseudotyped lentiviral vectors outperform human ERV lentivectors for transduction of T, B, NK and HSPCsSéverine Périan, Eva Castellano, Caroline Costa, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 13, 2024
In vivo CAR T cell therapy against angioimmunoblastic T cell lymphomaAdrien Krug, Aymen Saidane, Chiara Martinello, et al.
Blood|November 26, 2011
A novel lentiviral vector targets gene transfer into human hematopoietic stem cells in marrow from patients with bone marrow failure syndrome and in vivo in humanized miceCecilia Frecha, Caroline Costa, Didier Nègre, et al.
Cells|February 26, 2026
Engineering Bi-Specific CAR-NK Cells to Restore Antibody-Dependent Cellular Cytotoxicity in Solid TumorsJee Young Chung, Jung Eun Kim, Daseuri Cha, et al.
Molecular Therapy. Methods & Clinical Development|January 4, 2019
CD46 Null Packaging Cell Line Improves Measles Lentiviral Vector Production and Gene Delivery to Hematopoietic Stem and Progenitor CellsStosh Ozog, Craig X Chen, Elizabeth Simpson, et al.
Molecular Therapy. Oncology|May 22, 2026
Engineering precision oncology: Targeting tumors and immune cells with lentiviral vectorsJulia Rossi, Chiara Martinello, Riccardo Sorrentino, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 24, 2012
Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cellsCamille Lévy, Fouzia Amirache, Caroline Costa, et al.
Journal of Virology|April 1, 2011
Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptorsCecilia Frecha, Camille Lévy, Caroline Costa, et al.
Advances in Virology|March 21, 2014
Mutations in the H, F, or M Proteins Can Facilitate Resistance of Measles Virus to Neutralizing Human Anti-MV SeraHasan Kweder, Michelle Ainouze, Sara Louise Cosby, et al.
Pageof 12